Literature DB >> 6579706

The relationship between dose, pharmacokinetics, plasma-concentrations and antithrombotic effects of nafazatrom.

E Philipp, W Ritter, K Patzschke.   

Abstract

Nafazatrom is rapidly and almost completely absorbed after oral administration. However, the plasma levels of unchanged nafazatrom are very low, suggesting an extensive biotransformation during a first passage through the liver. The concentrations of nafazatrom in the plasma therefore, may only reflect indirectly the effective concentration at the receptor site. Concentrations, half-life and distribution of nafazatrom between aqueous and liquid compartments suggest that the cellular membrane may be the site of action.

Mesh:

Substances:

Year:  1983        PMID: 6579706     DOI: 10.1016/0049-3848(83)90368-7

Source DB:  PubMed          Journal:  Thromb Res Suppl        ISSN: 0896-0569


  1 in total

1.  Phase I clinical study of nafazatrom.

Authors:  G N Hortobagyi; N E Papadoupoulos; D Frye; J Ajani; J M Reuben
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.